Hamed Korsand
Analyst, BWS Financial
Replay available
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) Q3 2026 earnings conference call, held 2026-04-30. Replay captured from the company's public earnings webcast.

Analyst, BWS Financial
Chief Operating Officer
Chief Financial Officer
Chief Executive Officer
Good day and thank you for standing by. Welcome to the John B. Sanfilippo & Son, Inc. Third Quarter Fiscal 2026 Operating Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Jeffrey Sanfilippo, Chief Executive Officer. Please go ahead. Thank you, Rivka, and good morning, everyone, and welcome to our 2026 Third Quarter Earnings Conference Call. Thank you for joining us. On the call with me today is Jasper Sanfilippo, our COO, and Frank Pellegrino, our CFO. We may make some forward-looking statements today. These statements are based on our current expectations, and they involve certain risks and uncertainties. The factors that could negatively impact results are explained in the various SEC filings that we've made, including forms 10-K and 10-Q. We encourage you to refer to the filings to learn more about these risks and uncertainties that are inherent in our business. We delivered another strong quarter, achieving record top line sales growth, supported by our continued focus on driving volume across three of our sales channels. Total volume was consistent with last year, and the sequential quarter improvement is an early indication that our volume growth initiatives are beginning to gain traction. In particular, we are very encouraged by the improved performance in our commercial ingredients and contract manufacturing ...